Update – October 3, 2022
On September 23, 2022, the Honourable Chief Justice Popescul of the Saskatchewan Court of King’s Bench released his written decision approving the OxyContin® and OxyNEO® National Settlement Agreement as being fair, reasonable and in the best interest of Class Members. We are pleased that we are now one step closer to providing some compensation for the significant harms that have been caused by opioid addiction in connection with Oxy’s prescription and use.
The settlement provides for a total settlement payment of $20 million (CDN), $2 million of which is designated for provincial health insurers. A total of $18 million plus interest, minus court approved legal fees and disbursements, the costs of notice and claims administration, and applicable taxes, will be distributed to eligible class members.
After dismissal orders are all issued and become final, a Notice will be distributed and published in the media providing information about settlement approval. The claims process will thereafter begin, during which a Class Member and/or Family Class Member must file a claim with the court-appointed Claims Administrator by a deadline that is nine (9) months after the date the Notice is distributed.
Compensation won’t be distributed to approved Class Members and Family Class Members until sometime after the nine-month claims deadline has passed. We will communicate additional information about the Settlement and claims process as it becomes available.
A copy of the Settlement Approval decision can be found at the link below:
Update – July 19, 2017
The Honourable Justice Belobaba of The Ontario Superior Court of Justice approved the Settlement Agreement for the Oxycontin Class Action. A link to this Settlement Approval Order can be viewed here.
Notice of Certification and Proposed Settlement of Canadian Oxycontin and Oxyneo Litigation
Update – March 8, 2017
Update – October 21, 2010
Update – June 8, 2007: Oxycontin Class Action Commenced